There was a significant decrease in body weight and non-significant decrease in mean testicular weight of enrofloxacin treated rats.
Treatment of rats with TAA for three and six weeks resulted in a significant decrease in body weight gain, while the value of liver/body weight ratio was statistically increased.
A1254 at doses of 1.5 and 3 mg/kg/day resulted in a significant decrease in body weight, testes weight, epididymal and relative epididymal weight.
CsA treatment produced a significant decrease in body weight gain and consequently a decrease in the kidney weight of the CsA group as compared with the control group.
Results showed that CMZ injection caused a significant decrease in body weight gain along with significant decrease in the relative weights of the spleen and thymus.
Kids were no longer allowed to eat in classrooms or in the hallways at school; overall, they saw a 10percentt decrease in body weight.
C75-treated mice showed a marked decrease in body weight after each administration (close to 6% of initial body weight).
In fact we observed a 10% decrease in body weight in DIO mice study.
At the highest dose, a decrease in body weight gain was observed.
Consequently, more physical activity, holding caloric intake constant, will result in a decrease in body weight.
In Fl-intoxicated rats, water and pellet diet consumption significantly (p < 0.05) decreased with a decrease in body weight.
